EI
251.8
-0.32%↓
SAN
81.4
+0.15%↑
SHL.DE
45.95
-0.2%↓
ARGX
550.8
-1.18%↓
PHIA
23.17
+0.87%↑
EI
251.8
-0.32%↓
SAN
81.4
+0.15%↑
SHL.DE
45.95
-0.2%↓
ARGX
550.8
-1.18%↓
PHIA
23.17
+0.87%↑
EI
251.8
-0.32%↓
SAN
81.4
+0.15%↑
SHL.DE
45.95
-0.2%↓
ARGX
550.8
-1.18%↓
PHIA
23.17
+0.87%↑
EI
251.8
-0.32%↓
SAN
81.4
+0.15%↑
SHL.DE
45.95
-0.2%↓
ARGX
550.8
-1.18%↓
PHIA
23.17
+0.87%↑
EI
251.8
-0.32%↓
SAN
81.4
+0.15%↑
SHL.DE
45.95
-0.2%↓
ARGX
550.8
-1.18%↓
PHIA
23.17
+0.87%↑
24h
Praegune
Min
108
Max
109.85
Sissetulek | 68M 735M |
---|---|
Müük | -138M 5.3B |
P/E Sektori keskmine | 26.27 34.393 |
Aktsiakasum | 2.07 |
Dividenditootlus | 1.34 |
Kasumimarginaal | 13.92 |
EBITDA | 1.6B |
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +35.06% upside |
Dividenditootlus Sektori keskmine | 1.34% 2.54% |
---|
Turukapital | 38B 98B |
---|---|
Eelmine avamishind | 108.71 |
Eelmine sulgemishind | 109.95 |
By Acuity
19%
81%
28 / 374 Pingereas Healthcare
By Trading Central
Kindlus
Strong Bearish Evidence
121.15 / 123.55 Toetus ja vastupanu
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
7. aug 2025, 05:43 UTC
Germany's Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales
DJ
Loe
15. mai 2025, 08:36 UTC
Merck KGaA Shares Plunge After Outlook Cut on Tariff, Currency Risks
DJ
Loe
15. mai 2025, 05:25 UTC
Merck KGaA Cuts Outlook Amid Macroeconomic Challenges
DJ
Loe
7. aug 2025, 08:04 UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Group Ebitda Before Exceptional Items of EUR5.8B-EUR6.4B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Had Guided for 2025 Group Sales of EUR20.9B-EUR22.4B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Organic Growth in Ebitda Before Exceptional Items at 2%-7%
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth at 2%-6%
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Now Sees 2025 Group Ebitda Before Exceptional Items of EUR5.9B-EUR6.3B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Now Sees 2025 Organic Growth in Ebitda Before Exceptional Items at 4%-8%
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Cuts 2025 View To Sales EUR20.5B-EUR21.7B
DJ
Loe
7. aug 2025, 05:00 UTC
Analysts Saw Merck KGaA 2Q Sales at EUR5.32B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Organic Sales Growth at 2%-5%
DJ
Loe
7. aug 2025, 05:00 UTC
Analysts Saw Merck KGaA 2Q Ebitda Before Exceptional Items at EUR1.52B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Says It Faced Strong Currency Headwinds
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Adjusts 2025 View
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Raises 2025 Guidance for Organic Growth in Ebitda Before Exceptional Items
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA Narrows 2025 Organic Sales Growth Guidance
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA 2Q EBITDA EUR1.35B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA 2Q After-Tax Profit EUR655M
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA 2Q Sales EUR5.255B
DJ
Loe
7. aug 2025, 05:00 UTC
Merck KGaA 2Q Ebitda Before Exceptional Items EUR1.46B
DJ
Loe
7. aug 2025, 05:00 UTC
Germany's Merck KGaA Says 2Q Sales Grew 2% Organically
DJ
Loe
6. aug 2025, 14:14 UTC
Merck KGaA's Sales, Adjusted Earnings Expected to Be Little Changed -- Market Talk
DJ
Loe
15. mai 2025, 08:21 UTC
Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks
DJ
Loe
15. mai 2025, 06:53 UTC
Merck KGaA's Guidance Cut Should Cause Share-Price Pressure -- Market Talk
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA: Guidance Cut Reflects Impact of Current Macro-Economic, Geopolitical Environment
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q EBITDA EUR1.48B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Net Sales Between EUR20.9B and EUR22.4B
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 146 EUR 35.06%
Kõrge 182 EUR
Madal 100 EUR
Põhineb 10 Wall Streeti analüütiku instrumendi Merck KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
10 ratings
8
Osta
1
Hoia
1
Müü
Põhineb 10 analüütiku instrumendi Merck KGaA aktsia reitingul - viimase 3 kuu andmed.
By Trading Central
Lühikene perspektiiv
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Keskpikk perspektiiv
Neutral Evidence
The bullish and bearish events are balanced.
Pikk perspektiiv
Bearish Evidence
All events are bearish.
By Acuity
Uudiste sentiment
Väga tugevad tõusu märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$